Cost-effectiveness and cost-utility of a community pharmacist intervention in patients with depression (PRODEFAR study)

International Journal of Integrated Care

Judith Bosmans¹  Ana Fernández¹  Marian March²  Juan Bellon²  Maite Peñarrubia-Maria³  Maria Rubio-Valera⁴  Antoni Serrano-Blanco⁶ 

[1] Centre for Disability Research and Policy, Faculty of Health Sciences, The University of Sydney, Sydney, Australia;Primary Care Health Centre Bartomeu Fabrés Anglada, Institut Català de la Salut, Gavà, Spain;Faculty of Earth and Life Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;Fundació Sant Joan de Déu, Sant Boi de Llobregat, Spain;Red de Investigación en Actividades Preventivas y Promoción de la Salud en Atención Primaria (redIAPP);School of Pharmacy, Universitat de Barcelona, Barcelona, Spain), Pere Travé (School of Pharmacy, Universitat de Barcelona, Barcelona, Spain;

关键词: economics;    depressive disorder;    medication adherence;    antidepressive agents;    pharmaceutical services;    primary health care;   

DOI  :  10.5334/ijic.1953

来源: DOAJ

【 授权许可】

Unknown